Observational studyOpen heart2024

Effect of optimisation to contemporary HFrEF medical therapy with sacubitril/valsartan (Entresto) and dapaglifloziN on left Ventricular reverse remodelling as demonstrated by cardiac magnetic resonance (CMR) Imaging: the ENVI study.

Alice Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.